Menu

Blog

Jan 15, 2024

Novel regulator of immune evasion in cancer identified

Posted by in categories: biotech/medical, futurism

Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies, according to recent findings published in the Journal of Clinical Investigation.

“The study provides a molecular insight into understanding why some cannot be treated by the checkpoint blockade antitumor therapy, but others can,” said Deyu Fang, Ph.D., the Hosmer Allen Johnson Professor of Pathology and senior author of the study.

Antitumor immunotherapy is a type of treatment that helps the immune system in fighting cancer and includes a range of therapy types, such as . Immune checkpoints help prevent the immune system from being too strong and eradicating other , including .

Comments are closed.